Bio-musical will close in January
Broadway musical “Chaplin” will shutter at the Barrymore Theater on Jan. 6 after a run of about 4 1/2 months.
Tuner has posted so-so sales since it began previews Aug. 21 and largely earned mixed to negative reviews in the wake of its Sept. 10 opening, although star Rob McClure generally attracted glowing notices in the title role of the bio-tuner about the silent film legend. The writing was most clearly on the wall, however, when “Chaplin” proved one of the rare musicals not to experience a spike in sales over Thanksgiving week, during which a surging tide of tourists lifts B.O. at most productions on the Rialto. The musical’s sales slipped a bit compared to the prior frame, and attendance fell to 57% of total capacity.
Producers have already bet the show may have some legs on the road and internationally given the fame of Charlie Chaplin and his iconic work. Last week the producing team announced it was laying the groundwork for a U.S. tour that would aim to go out in fall 2014, with an international incarnation to follow.
“Chaplin” is the first Broadway outing to be lead produced by Bob and Mindy Rich’s Rich Entertainment Group. Also on the producing team are John and Claire Caudwell, Roy Gabay, Viertel Roth Frankel Baruch Group, Chunsoo Shin/Waxman-Dokton and Broadway Across America.
Musical comes from composer-lyricist Christopher Curtis, who also co-wrote the book with Thomas Meehan (“Annie,” “Hairspray”). Warren Carlyle (“Hugh Jackman, Back on Broadway”) helms and choreographs. Alongside McClure, cast includes Jim Borstelmann, Jenn Colella, Erin Mackey and Christiane Noll.
Show will stick it out through the holidays, hoping to catch some extra coin during the holiday boom of the week between Christmas and New Year’s Day, traditionally the Main Stem’s most profitable sesh of the year.